The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice

BACKGROUND: Osteoclasts are key determinant cellular components implicated in the development and progression of disorders driven by bone damage. Herein, we studied the upshot of T007, an antagonist of peroxisome proliferator-activated receptor-gamma (PPARγ), on osteoclastogenesis using cell and ani...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiang, Ning, Lei, Ma, Jianjun, Xie, Ziang, Zhao, Xiangde, Wang, Gangliang, Wan, Xinyu, Qiu, Pengcheng, Yao, Teng, Wang, Haoming, Fan, Shunwu, Wan, Shuanglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815399/
https://www.ncbi.nlm.nih.gov/pubmed/31655621
http://dx.doi.org/10.1186/s12964-019-0442-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815399/
https://www.ncbi.nlm.nih.gov/pubmed/31655621
http://dx.doi.org/10.1186/s12964-019-0442-3

Ejemplares similares